Connection

Ernest Camp to Antimetabolites, Antineoplastic

Back to Details
This is a "connection" page, showing publications Ernest Camp has written about Antimetabolites, Antineoplastic.
Ernest Camp
Connection Strength
0.612
Antimetabolites, Antineoplastic
  1. Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther. 2013 Apr; 20(4):222-8.
    View in: PubMed
    Score: 0.407
  2. Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. J Surg Res. 2012 Aug; 176(2):359-66.
    View in: PubMed
    Score: 0.093
  3. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer. J Surg Res. 2004 Aug; 120(2):178-88.
    View in: PubMed
    Score: 0.056
  4. Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer. J Am Coll Surg. 2004 Aug; 199(2):249-58.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.